Chemours
499 hedge funds and large institutions have $7.18B invested in Chemours in 2017 Q3 according to their latest regulatory filings, with 84 funds opening new positions, 131 increasing their positions, 173 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.79% less ownership
Funds ownership: 77.51% → 76.72% (-0.79%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
24% less repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 173
Holders
499
Holding in Top 10
5
Calls
$114M
Puts
$100M
Top Buyers
| 1 | +$130M | |
| 2 | +$65.7M | |
| 3 | +$51M | |
| 4 |
Millennium Management
New York
|
+$46.7M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$43.8M |
Top Sellers
| 1 | -$210M | |
| 2 | -$107M | |
| 3 | -$52M | |
| 4 |
SCM
Sirios Capital Management
Boston,
Massachusetts
|
-$37.4M |
| 5 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$33.5M |